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Long non-coding RNAs and The Hallmarks of Cancer:  
A “Linc” between 
Introduction 
 
 
 
Features and Classification of lncRNAs Mechanisms of Action 
Figure 1: Classification of lncRNAs. From up to 
down: sense, antisense, bidirectional, intronic 
and intergenic.    
Adapted from: Rinn JL, Chang HY. Annu Rev 
Biochem. 81: 145-66 (2012). 
  
• Endogenous cellular RNA transcripts 
that lack an open reading frame of 
significant length and do not code for 
proteins.  
• Are transcribed by RNA Polymerase II, 
polyadenylated, spliced and 5’ capped.  
• Are localized in nuclear or cytosolic 
fractions.  
•Display lower conservation than 
protein-coding genes, but they 
preserve the secondary structure, 
which implies functional conservation.  
•There are 5 categories regarding their 
location relative to nearby protein-
coding genes (Figure 1).   
Sense: When the lncRNA sequence 
overlaps one or more exons of another 
protein-coding gene on the same strand.  
Antisense: When they overlap with the 
opposite strand of a protein-coding gene 
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Bidirectional or divergent: When the 
lncRNA expression and a coding 
transcript on the opposite strand is 
initiated in close genomic proximity. 
Intronic: When they derive from an 
intronic region of a protein-coding gene.   
Intergenic (LincRNAs): When they are 
distant from protein-coding regions, at 
least 5 kb away.  
Legend:  
 Coding region  
 lncRNA sequence  
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Materials and Methods 
LncRNAs and The Hallmarks of Cancer: The connection between lncRNAs and cancer 
Therapeutic Perspectives Conclusions 
Objectives 
LncRNAs have been found to be strongly connected with cancer, showing an altered pattern of expression different from the normal cell tissues. Many lncRNAs are up-regulated or down-regulated in cancers and can act as oncogenes or tumor suppressor 
genes. To become malignant, cells follow a multistep process in which they progressively acquire different competences that will ultimately confer them the tumorigenic phenotype. Some lncRNAs have been reported to regulate such competences, known as 
the hallmarks of cancer which were named and described  by Hanahan and Weinberg. We can see this relation between some lncRNAs and cancer below:  
The methodology used for this review is a research through the PubMed database, followed by an extensive synthesis of 
information selecting those aspects that were more suitable for accomplishing the aims of this review. Some filters were 
selected for the search such as “review” and “last 10 years” to obtain the latest information. Key words: lncRNAs, cancer, 
HOTAIR 
The aim of this review is to describe the types and features of lncRNAs, their underlying mechanisms and focus on the 
emerging roles of these lncRNAs in the field of cancer. Furthermore, HOTAIR will be characterized as an example of a 
metastasis related lncRNA. Finally, details will be given on how these transcripts could be used as novel therapeutic and 
diagnostic tools within cancer.  
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The cell cycle has powerful programs to negatively regulate 
proliferation, which is mostly executed thanks to tumor suppressor 
genes. LincRNA-p21 is a direct target of the p53 tumor suppressor. 
Depletion of this lincRNA alters the expression of some of this indirect 
p53-target genes that would inhibit apoptosis, favoring tumorigenesis.  Telomeres are protective multiple repeat 
sequences that avoid aberrant fusions 
between chromosomes but that shorten in 
each cell division. When telomeres are 
eroded, the cell dies or enters senescence. 
However, tumor cells are able to circumvent 
the loss of telomeres by activating the 
expression of telomerase, an enzyme that 
extends telomeric DNA. TERRA is a group of 
lncRNAs that have been discovered to be a 
negative regulator of the telomerase 
enzyme.  
Metastasis is a multistep process involving 
complex interactions and regulatory 
mechanisms that enable cells from the 
primary tumor to invade, disseminate and 
develop distant metastases. Cells may 
undergo several changes in morphology, cell-
cell and cell-tumor stroma communications 
and they can also escape the immune 
surveillance. HOTAIR is one identified lncRNA 
with functional importance in metastasis 
(scheme on the right).  
An “angiogenic switch” is undergone by cancer cells, an ability that 
promotes the formation, which is usually very regulated,  of new vessels 
to sustain the neoplastic growth. The lncRNA MVIH has been discovered 
to be associated with frequent microvascular invasion in hepatocellular 
carcinoma when it is overexpressed.  
In cancer cells apoptosis is attenuated and 
most of the cells show an imbalance between 
antiapoptotic and proapoptotic proteins. 
PANDA lncRNA is a p21 promoter-derived 
transcript that is activated by DNA damage 
through the TP53 pathway. It binds to the NF-
YA transcription factor limiting the expression 
of proapoptotic genes and consequently 
repressing apoptosis. It seems to be 
selectively induced in metastatic ductal 
carcinomas.  
Normal tissues control cell proliferation 
thanks to growth-promoting signals in order 
to ensure a proper tissue architecture and 
function, which are deregulated in cancer 
cells. Steroid receptor RNA (SRA) is a lncRNA 
that forms a complex with Steroid Receptor 
Coactivator 1 (SRC-1) to activate transcription 
and it acts as a coactivator of the sex steroid 
hormones receptors. If SRA increases, the 
steroid receptor for progesterone and 
estrogens triggers an altered action that 
would occur during breast tumorigenesis. 
The central dogma of gene expression before the 20th century was that DNA is transcribed into mRNAs which in turn are used as a template for protein synthesis. However, further studies revolutionized such view as they revealed an unexpected finding: 
although the vast majority of the genome is transcribed, only a small proportion of genes encode proteins. These RNA molecules that lack protein-coding potential are collectively referred to as non-coding RNAs (ncRNAs). According to their size, ncRNAs are 
subdivided into two major groups: small non-coding RNAs which are typically 20-200 nucleotides in length, and long non-coding RNAs (lncRNAs) ranging from 200 nucleotides to >100kB. Although at first little was known about lncRNAs which were described 
as “dark matter”, it has increasingly become clear that they have a variety of essential biological functions and are critical for gene expression regulation. In addition, lncRNAs have shown to be deregulated in many human cancers.  
HOTAIR: A metastasis related LincRNA 
• 2kB long 
intergenic RNA 
• Resides on the 
HOXC cluster (chr. 
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Binds to the Protein 
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All this complex acts in trans on different dominions along the genome, 
where it leads to EPIGENETIC GENE SILENCING (change of the chromatin 
state) through H3K27 trimethylation and H3K4 demethylation. 
Invasion and metastasis 
promotion 
In cancer: Overexpression of 
HOTAIR retargets PRC2 to an 
alternative gene set A shift of 
the repression pattern 
condcutive to:   
HOTAIR is up-regulated in 16 
cancer types and associated with 
poorer prognosis 
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• Specific expression 
• Their measurment directly represents the levels of 
the active molecule  
E.g: PCA3 lncRNA for 
early-stage prostate 
tumors detection 
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Strategies: Silencing lncRNAs with antisense oligonucleotides, 
disrupting their structure or blocking their function with small 
molecule inhibitors 
Strategies: Replacement therapy with synthetic lncRNAs    
LncRNAs can act at every level of gene regulation as they are a key regulatory layer in global gene expression:  
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Figure 3: HOTAIR mechanism of action. It guides 
PRC2 to specific genome loci to induce repression 
of transcription through patterns of methylation. 
Adapted from: Loewen G, Jayawickramarajah J, 
Zhuo Y. J Hematol Oncol. 7, 1-10 (2014). 
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Figure 2: LncRNAs mechanisms of action within the cell.  Adapted from: Gutschner T., Diederichs S. RNA Biol. 9, 703-19 (2012) 
• LncRNAs are members of the non-coding universe that have broad diverse roles all over the cellular biology and seem to orchestrate 
many proteins and other non-coding RNAs to ultimately modulate cell functions. 
 
• Some of them have critical roles in the pathways pivotal to cancer, which clearly suggests their potential for developing new 
methods both for therapy and early diagnosis.  
 
• We are only at the tip of the iceberg but the non-coding transcripts may eventually rival proteins in their versatility as 
regulators of genetic information.  
Paraspeckles 
LncRNA NEAT1 forms paraspeckles (cellular 
substructures) Scaffolding functions 
Proteins 
LncRNAs: MALAT1 
Blocking of the spliceosome 
binding site 
LncRNAs: HULC 
LncRNAs: H19 
LncRNAs can 
sequester microRNAs 
to inhibit them.  
LncRNAs:  
